157 filings
10-K/A
2023 FY
AUGX
Augmedix Inc
Annual report (amended)
29 Apr 24
4:03pm
8-K
AUGX
Augmedix Inc
18 Apr 24
Entry into a Material Definitive Agreement
4:29pm
8-K
AUGX
Augmedix Inc
15 Apr 24
Entry into a Material Definitive Agreement
4:05pm
S-8
AUGX
Augmedix Inc
27 Mar 24
Registration of securities for employees
7:53pm
10-K
2023 FY
AUGX
Augmedix Inc
Annual report
26 Mar 24
5:16pm
8-K
06lo2x
18 Mar 24
Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023
4:01pm
8-K
1nnufe2r
9 Jan 24
Entry into a Material Definitive Agreement
4:05pm
8-K
fh1jqadmybg42mb
5 Jan 24
Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue
4:05pm
8-K
m0lfm8mz
29 Nov 23
Entry into a Material Definitive Agreement
5:11pm
8-K
fvme6ij
21 Nov 23
Augmedix Announces Closing of Public Offering of Common Stock, Including Additional Investments from HCA Healthcare
12:00am
8-K
94i7wzc
20 Nov 23
Augmedix Announces Proposed Public Offering of 5,500,000 Shares of Common Stock
4:05pm
424B5
xczr1
17 Nov 23
Prospectus supplement for primary offering
4:08pm
424B5
g1cqo5xn x3mofumf1
15 Nov 23
Prospectus supplement for primary offering
5:14pm
8-K
0f6st6tjfnj2h2v
15 Nov 23
Other Events
4:08pm
8-K
ssv8gwenr21g
6 Nov 23
Augmedix Delivers 50% Revenue Growth and Expanded Gross Margins for Third Quarter of 2023
4:03pm
8-K
bu7758i4a4wx8hw0
6 Nov 23
Entry into a Material Definitive Agreement
4:03pm
8-K
lvjupw4r
13 Oct 23
Entry into a Material Definitive Agreement
4:30pm
8-K
v130h3im9z h3zq
7 Aug 23
Augmedix Delivers 47% Revenue Growth and Expanded Gross Margins for Second Quarter of 2023
4:02pm